Imaging breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography-3

<p><b>Copyright information:</b></p><p>Taken from "Imaging breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography"</p><p>Breast Cancer Research 2004;7(1):R33-R45.</p><p>Published online 8 Nov 2004</p><p>PMCID:PMC1064097.</p><p>Copyright © 2004 Papantoniou et al., licensee BioMed Central Ltd.</p>. Scintimammography, left lateral projection: Tc-(V)DMSA at 10 min and 60 min (i-ii). Diffuse semi-lunar accumulation (arrow) extending behind the nipple, more prominent in the late image. Tc-Sestamibi scan was not performed in this patient

Correlation of progesterone receptor (PR) with log transformed tumor-to-background ratios (T/B) of pentavalent dimercaptosuccinic acid (V)DMSA uptake at 10 min and 60 min, and sestamibi (MIBI) uptake at 10 min and 60 min

<p><b>Copyright information:</b></p><p>Taken from "Relationship of cell proliferation (Ki-67) to Tc-(V)DMSA uptake in breast cancer"</p><p>Breast Cancer Research 2003;6(2):R56-R62.</p><p>Published online 11 Dec 2003</p><p>PMCID:PMC400650.</p><p>Copyright © 2004 Papantoniou et al., licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</p> CI, confidence interval